[HTML][HTML] Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases

J Ren, Y Bi, JR Sowers, C Hetz, Y Zhang - Nature Reviews Cardiology, 2021 - nature.com
Cardiovascular diseases (CVDs), such as ischaemic heart disease, cardiomyopathy,
atherosclerosis, hypertension, stroke and heart failure, are among the leading causes of …

[HTML][HTML] Metformin beyond an anti-diabetic agent: A comprehensive and mechanistic review on its effects against natural and chemical toxins

A Malaekeh-Nikouei, S Shokri-Naei… - Biomedicine & …, 2023 - Elsevier
In addition to the anti-diabetic effect of metformin, a growing number of studies have shown
that metformin has some exciting properties, such as anti-oxidative capabilities, anticancer …

[HTML][HTML] True or False? Alzheimer's disease is Type 3 Diabetes: Evidences from Bench to Bedside.

Y Peng, S Yao, Q Chen, H Jin, M Du, Y Xue… - Ageing research reviews, 2024 - Elsevier
Globally, Alzheimer's disease (AD) is the most widespread chronic neurodegenerative
disorder, leading to cognitive impairment, such as aphasia and agnosia, as well as mental …

AGEs-induced and endoplasmic reticulum stress/inflammation-mediated regulation of GLUT4 expression and atherogenesis in diabetes mellitus

M Passarelli, UF Machado - Cells, 2021 - mdpi.com
In recent decades, complex and exquisite pathways involved in the endoplasmic reticulum
(ER) and inflammatory stress responses have been demonstrated to participate in the …

Metformin a potential pharmacological strategy in late onset Alzheimer's disease treatment

SR Poor, M Ettcheto, A Cano, E Sanchez-Lopez… - Pharmaceuticals, 2021 - mdpi.com
Alzheimer's disease (AD) is one of the most devastating brain disorders. Currently, there are
no effective treatments to stop the disease progression and it is becoming a major public …

Combined donepezil with astaxanthin via nanostructured lipid carriers effective delivery to brain for Alzheimer's disease in rat model

MK Shehata, AA Ismail, MA Kamel - International Journal of …, 2023 - Taylor & Francis
Introduction Donepezil (DPL), a specific acetylcholinesterase inhibitor, is used as a first-line
treatment to improve cognitive deficits in Alzheimer's disease (AD) and it might have a …

[HTML][HTML] Effect of metformin treatment on memory and hippocampal neurogenesis decline correlated with oxidative stress induced by methotrexate in rats

N Sritawan, K Suwannakot, S Naewla… - Biomedicine & …, 2021 - Elsevier
Metformin is currently used as a first-line drug to treat patients with type 2 diabetes. Previous
studies have demonstrated that metformin has antioxidant properties and reduces …

[HTML][HTML] Combined effect of metformin and gallic acid on inflammation, antioxidant status, endoplasmic reticulum (ER) stress and glucose metabolism in fructose-fed …

TO Obafemi, KF Jaiyesimi, AA Olomola… - Toxicology Reports, 2021 - Elsevier
Over time, diabetes patients usually need combination therapy involving two or more agents,
including phytonutrients to attain therapeutic targets. The purpose of this research is to …

Comparison of malondialdehyde levels and superoxide dismutase activity in resveratrol and resveratrol/donepezil combination treatment groups in Alzheimer's …

YL Rao, B Ganaraja, A Marathe, PA Manjrekar, T Joy… - 3 Biotech, 2021 - Springer
The aim of this study was to determine the malondialdehyde (MDA) level and superoxide
dismutase (SOD) activity in colchicine induced Alzheimer's disease (AD), resveratrol (RS) …

Effects of antidiabetic agents on Alzheimer's disease biomarkers in experimentally induced hyperglycemic rat model by streptozocin

SK Ali, RH Ali - PLoS One, 2022 - journals.plos.org
Background Alzheimer's disease is the most common cause of dementia in the elderly
population. It is characterized by the accumulation of amyloid β and intraneuronal …